Tenax Therapeutics (TENX) Gains from Investment Securities (2016 - 2017)
Historic Gains from Investment Securities for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to $3.8 million.
- Tenax Therapeutics' Gains from Investment Securities fell 679.88% to $3.8 million in Q3 2017 from the same period last year, while for Sep 2017 it was $3.8 million, marking a year-over-year decrease of 679.88%. This contributed to the annual value of -$1000.0 for FY2023, which is 13447.09% down from last year.
- As of Q3 2017, Tenax Therapeutics' Gains from Investment Securities stood at $3.8 million, which was down 679.88% from $4.3 million recorded in Q2 2017.
- Over the past 5 years, Tenax Therapeutics' Gains from Investment Securities peaked at $4.7 million during Q1 2017, and registered a low of -$2519.0 during Q2 2014.
- In the last 5 years, Tenax Therapeutics' Gains from Investment Securities had a median value of $3.7 million in 2014 and averaged $2.4 million.
- Per our database at Business Quant, Tenax Therapeutics' Gains from Investment Securities skyrocketed by 718996.21% in 2014 and then plummeted by 679.88% in 2017.
- Over the past 5 years, Tenax Therapeutics' Gains from Investment Securities (Quarter) stood at $50678.0 in 2013, then soared by 7189.96% to $3.7 million in 2014, then grew by 1.58% to $3.8 million in 2015, then tumbled by 98.02% to $74388.0 in 2016, then surged by 4996.45% to $3.8 million in 2017.
- Its Gains from Investment Securities was $3.8 million in Q3 2017, compared to $4.3 million in Q2 2017 and $4.7 million in Q1 2017.